Pinelli Valentina, Roca Elisa, Lucchini Silvia, Laroumagne Sophie, Loundou Anderson, Dutau Hervé, Maldonado Fabien, Astoul Philippe
Division of Pneumology, Hospital S. Bartolomeo, Sarzana, Italy.
Respiration. 2015;89(6):558-64. doi: 10.1159/000381922. Epub 2015 May 8.
Careful clinical staging in patients with malignant pleural mesothelioma (MPM) is fundamental in management planning. Positron emission tomography/computed tomography (PET/CT) is increasingly recognized as an important staging modality.
The purpose of this study was to assess whether the metabolic activity of the pleural tumor detected with PET/CT correlates with specific endoscopic features and pleural distribution of the lesions as assessed by medical thoracoscopy.
Consecutive patients with MPM and available PET/CT performed before thoracoscopy were separated into 2 groups, according to their standardized uptake value (SUV). Kaplan-Meier-analysis for survival was performed on groups with low and high SUV. Agreement between PET/CT and thoracoscopy evaluation was analyzed using Cohen's kappa coefficient. The Wilcoxon test was used to compare the median SUV, and the χ(2) test was used to evaluate differences in endoscopic findings.
A total of 32 patients were included. The median maximum SUV (SUV max) was 6.1 and patients were separated into 2 groups based on this cutoff. Patients with SUV max <6.1 had a better survival than those with SUV max ≥6.1 (p = 0.005). The comparison between PET/CT and thoracoscopy showed a fair agreement for visceral and diaphragmatic pleural involvement and moderate agreement for the presence of nodular lesions. There was a statistically significant association between median SUV max and visceral pleural involvement; nodular lesions and visceral pleural involvement were more common in the high-SUV group than in the low-SUV group (p = 0.0012 and p = 0.03, respectively).
PET/CT data may be predictive of thoracoscopic features of MPM associated with prognosis and staging, but the correlation is moderate at best. A degree of disagreement exists between these two modalities, which supports thoracoscopy as the gold standard for assessment of local invasion in MPM.
恶性胸膜间皮瘤(MPM)患者的仔细临床分期是管理规划的基础。正电子发射断层扫描/计算机断层扫描(PET/CT)越来越被认为是一种重要的分期方式。
本研究的目的是评估PET/CT检测到的胸膜肿瘤代谢活性是否与医学胸腔镜评估的特定内镜特征和病变的胸膜分布相关。
将连续的MPM患者且在胸腔镜检查前进行了PET/CT检查的患者,根据其标准化摄取值(SUV)分为2组。对低SUV组和高SUV组进行生存的Kaplan-Meier分析。使用Cohen卡方系数分析PET/CT与胸腔镜评估之间的一致性。采用Wilcoxon检验比较SUV中位数,采用χ²检验评估内镜检查结果的差异。
共纳入32例患者。SUV最大值(SUV max)中位数为6.1,并据此将患者分为2组。SUV max<6.1的患者比SUV max≥6.1的患者生存更好(p = 0.005)。PET/CT与胸腔镜检查之间的比较显示,对于脏层和膈胸膜受累情况一致性尚可,对于结节性病变的存在一致性中等。SUV max中位数与脏层胸膜受累之间存在统计学显著关联;高SUV组的结节性病变和脏层胸膜受累比低SUV组更常见(分别为p = 0.0012和p = 0.03)。
PET/CT数据可能预测与预后和分期相关的MPM的胸腔镜特征,但相关性充其量为中等。这两种方式之间存在一定程度的不一致,这支持胸腔镜检查作为MPM局部侵犯评估的金标准。